Showing results (141-150 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Medicine|June 2, 2021
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic HematopathologyMazen Osman, Zeynettin Akkus, Dragan Jevremovic, et al.
American Journal of Hematology|August 29, 2018
Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative casesSahrish Shah, Animesh Pardanani, Yoseph C Elala, et al.
Leukemia|October 29, 2011
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patientsM M Patnaik, C A Hanson, J M Hodnefield, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 25, 2016
Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipientsM Damlaj, G Bartoo, R Cartin-Ceba, et al.
American Journal of Hematology|February 2, 2018
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosisAyalew Tefferi, Daniel K Partain, Jeanne M Palmer, et al.
American Journal of Hematology|April 28, 2011
Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patientsMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
American Journal of Hematology|May 21, 2013
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromesNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
American Journal of Hematology|January 22, 2013
Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevanceMrinal M Patnaik, Terra L Lasho, Christy M Finke, et al.
Cancer Medicine|January 27, 2015
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutationsMuhammad A Mir, Samith T Kochuparambil, Roshini S Abraham, et al.
British Journal of Haematology|November 3, 2021
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive casesAyalew Tefferi, Jaya Kittur, Faiqa Farrukh, et al.
Pageof 32